Cost-Effectiveness Analysis of Disease-Modifying Therapies for Early Alzheimer's Disease in China.

Dong S, Gao K, Lin W, Chen W, Liu H, Wang Q, Yi Z

Open source

DOI
10.1007/s40120-026-01073-0
Published
2026 Oct 30
Container
Neurology and therapy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40120-026-01073-0,
  title = {Cost-Effectiveness Analysis of Disease-Modifying Therapies for Early Alzheimer's Disease in China.},
  author = {Dong S and Gao K and Lin W and Chen W and Liu H and Wang Q and Yi Z},
  year = {2026},
  journal = {Neurology and therapy},
  doi = {10.1007/s40120-026-01073-0},
  url = {https://doi.org/10.1007/s40120-026-01073-0}
}

RIS

TY  - JOUR
TI  - Cost-Effectiveness Analysis of Disease-Modifying Therapies for Early Alzheimer's Disease in China.
AU  - Dong S
AU  - Gao K
AU  - Lin W
AU  - Chen W
AU  - Liu H
AU  - Wang Q
AU  - Yi Z
PY  - 2026
JO  - Neurology and therapy
DO  - 10.1007/s40120-026-01073-0
UR  - https://doi.org/10.1007/s40120-026-01073-0
ER  - 

APA

S, D., K, G., W, L., W, C., H, L., Q, W., & Z, Y. (2026). Cost-Effectiveness Analysis of Disease-Modifying Therapies for Early Alzheimer's Disease in China.. Neurology and therapy. https://doi.org/10.1007/s40120-026-01073-0

Source records